Login
  • Home
  • Medicines
  • TREVICTA 175 mg, 263 mg, 350 mg, 525 mg prolonged release suspension for injection

TREVICTA 175 mg, 263 mg, 350 mg, 525 mg prolonged release suspension for injection

*
Pharmacy Only: Prescription

  • Company:

    Janssen Sciences Ireland

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Paliperidone Palmitate

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/14/971/007 175 milligram(s) N05AX,N05AX13 Prolonged-release suspension for injection EU/1/14/971/008 263 milligram(s) N05AX,N05AX13 Prolonged-release suspension for injection EU/1/14/971/009 350 milligram(s) N05AX,N05AX13 Prolonged-release suspension for injection EU/1/14/971/010 525 milligram(s) N05AX,N05AX13 Prolonged-release suspension for injection